Literature DB >> 7312934

Diazepam kinetics in relation to age and sex.

H R Ochs, D J Greenblatt, M Divoll, D R Abernethy, H Feyerabend, H J Dengler.   

Abstract

27 male volunteers aged 20 to 91 years, and 13 female volunteers aged 21 to 33 years, received single 5 to 10 mg doses of diazepam intravenously. Diazepam pharmacokinetics were determined from concentrations measured in multiple plasma samples drawn during 7 days after each dose. Diazepam elimination half-life among males (mean: 66 h) increased significantly with age (r = 0.53, p less than 0.005). Volume of distribution (mean: 1.39 liters/kg) also increased significantly with age (r = 0.67, p less than 0.001). Clearance of total diazepam in males (mean: 0.42 ml/min/kg) tended to decline with age (r = 0.32), but the association was of borderline significance (p = 0.1). Diazepam was extensively bound to plasma protein, with a mean free fraction among male subjects of 1.34%. Free fraction tended to increase with age (r = 0.14). Correction of volume of distribution and clearance for individual differences in binding did not alter the conclusions. Compared to young males, young females had larger volumes of distribution (1.87 vs. 1.34 liters/kg) and higher total clearance (0.63 vs. 0.49 ml/min/kg). These differences were even greater after correction for sex-related changes in protein binding. Elimination half-life did not differ between sexes. Since both age and sex can influence diazepam disposition, both should be considered as independent variables in studies of diazepam pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7312934     DOI: 10.1159/000137524

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  17 in total

Review 1.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 2.  Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations.

Authors:  I Bernus; R G Dickinson; W D Hooper; M J Eadie
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

Review 3.  Changed pharmacokinetics under the influence of age.

Authors:  D R Uges; R Schootstra
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

Review 4.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

5.  Reduced single-dose clearance of clobazam in elderly men predicts increased multiple-dose accumulation.

Authors:  D J Greenblatt; M Divoll; S K Puri; I Ho; M A Zinny; R I Shader
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 6.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

7.  Disposition of clotiazepam: influence of age, sex, oral contraceptives, cimetidine, isoniazid and ethanol.

Authors:  H R Ochs; D J Greenblatt; B Verburg-Ochs; J S Harmatz; H Grehl
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 8.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

9.  Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; L J Moschitto; R B Smith; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

10.  Diazepam absorption: effects of age, sex, and Billroth gastrectomy.

Authors:  H R Ochs; H Otten; D J Greenblatt; H J Dengler
Journal:  Dig Dis Sci       Date:  1982-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.